血乳酸水平在评估肝衰竭患者预后中的应用

李会; 王永刚; 苏海滨

doi:10.3969/j.issn.1001-5256.2020.11.048

血乳酸水平在评估肝衰竭患者预后中的应用

DOI: 10.3969/j.issn.1001-5256.2020.11.048

1. 解放军总医院第五医学中心肝衰竭诊疗与研究中心
2. 解放军总医院第五医学中心重症医学中心

基金项目:

医院创新课题（KT2009011）；

详细信息

中图分类号: R575.3
计量
- 文章访问数: 939
- HTML全文浏览量: 14
- PDF下载量: 91
- 被引次数: 7
出版历程
- 收稿日期: 2020-05-07
- 出版日期: 2020-11-20

Application of blood lactate level in evaluating the prognosis of liver failure patients

Liver Failure Treatment and Research Center,The Fifth Medical Center of Chinese PLA General Hospital
Critical Care Center,The Fifth Medical Center of Chinese PLA General Hospital

Research funding:

摘要

摘要:
肝衰竭时因乳酸代谢障碍使机体乳酸水平升高,近年来研究血乳酸对肝衰竭的预后具有较高的预测价值。结合近年来的研究发现,介绍LiFe评分预测模型,就血乳酸水平在肝衰竭患者中临床应用的国内外进展进行综述。认为高乳酸水平是肝衰竭患者不良预后的独立危险因素,提出乳酸可作为评估肝衰竭严重程度及预后的重要指标,并能进一步优化相关肝病预后评分系统。
- 肝功能衰竭 /
- 乳酸 /
- 预后 /
- LiFe评分
Abstract:
As lactate is elevated due to lactate metabolic disorder in liver failure,recent studies have shown that blood lactate has a high value in predicting the prognosis of liver failure. With reference to the research findings in recent years,this article introduces the prediction model of LiFe score and reviews the advances in the clinical application of blood lactate level in patients with liver failure in China and foreign countries. It is believed that a high lactate level is an independent risk factor for poor prognosis of liver failure patients,and it is proposed that lactate can be used as an important indicator to evaluate the severity and prognosis of liver failure and further optimize the scoring system for the prognosis of related liver diseases.
- liver failure /
- lactic acid /
- prognosis /
- LiFe score

HTML全文

参考文献(35)

[1]CHEN J,SU HB,HU JH.An excerpt of acute-on-chronic liver failure:Consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL) 2019 update[J].JClin Hepatol,2019,35(9):1933-1936.(in Chinese)陈婧，苏海滨，胡瑾华．《2019年亚太肝病学会共识建议:慢加急性肝衰竭管理更新》摘译[J]．临床肝胆病杂志，2019,35(9):1933-1936．

[2]HAAS SA,LANGE T,SAUGEL B,et al.Severe hyperlactatemia,lactate clearance and mortality in unselected critically ill patients[J].Intensive Care Med,2016,42(2):202-210．

[3]JANSEN TC,van BOMMEL J,SCHOONDERBEEK FJ,et al.Early lactate-guided therapy in intensive care unit patients:Amulticenter,open-label,randomized controlled trial[J].Am J Respir Crit Care Med,2010,182(6):752-761．

[4]BURROUGHS A,GARCOVICH M,VEMALA V,et al.Admission serum lactate is a strong predictor of outcome in cirrhotics admitted to intensive care unit,and when added to the liverspecifc scores of model for end-stage liver disease or UKmodel for end-stage liver disease,improves their respective predictive value[J].Gut,2010,59:A13．

[5]ZHOU GL,XU SL,LUO YM,et al.Clinical significance of lactic acid measurement in evaluating the prognosis of patients with liver failure[J].Jiangxi Med J,2018,53(7):712-713,748.(in Chinese)周观林，许守连，罗颖敏，等．乳酸测定在评估肝衰竭患者预后中的临床意义[J]．江西医药，2018,53(7):712-713,748．

[6]JEPPESEN JB,MORTENSEN C,BENDTSEN F,et al.Lactate metabolism in chronic liver disease[J].Scand J Clin Lab Invest,2013,73(4):293-299．

[7]VITIN AA,AZAMFIREI L,TOMESCU D,et al.Perioperative management of lactic acidosis in end-stage liver disease patient[J].J Crit Care Med(Targu Mures),2017,3(2):55-62．

[8]van HALL G.Lactate kinetics in human tissues at rest and during exercise[J].Acta Physiol(Oxf),2010,199:499-508．

[9]WANG WC,CHOU CK,CHUANG MC,et al.Elevated levels of liver methylglyoxal and d-lactate in early-stage hepatitis in rats[J].Biomed Chromatogr,2018,32(2):1-8．

[10]MASYUK M,WERNLY B,LICHTENAUER M,et al.Prognostic relevance of serum lactate kinetics in critically ill patients[J].Intensive Care Med,2019,45(1):55-61．

[11]YANG CS,QIU HB,YANG YZ,et al.Prospective research on the prognosis of septic shock based on the change of lactate concentration in arterial blood[J].Chin J Surg,2009,47(9):685-688.(in Chinese)杨从山，邱海波，黄英姿，等．动态监测动脉血乳酸水平对感染性休克患者预后评价的前瞻性研究[J]．中华外科杂志，2009,47(9):685-688．

[12]DROLZ A,HORVATITS T,ROEDL K,et al.Acid-base status and its clinical implications in critically ill patients with cirrhosis,acute-on-chronic liver failure and without liver disease[J].Ann Intensive Care,2018,8(1):48．

[13]SCHEINER B,LINDNER G,REIBERGER T,et al.Acid-base disorders in liver disease[J].J Hepatol,2017,67(5):1062-1073．

[14]ROSE CF.Increase brain lactate in hepatic encephalopathy:Cause or consequence?[J].Neurochem Int,2010,57(4):389-394．

[15]CHAVARRIA L,ROMERO-GIMENEZ J,MONTEAGUDO E,et al.Real-time assessment of13C metabolism reveals an early lactate increase in the brain of rats with acute liver failure[J].NMR Biomed,2015,28(1):17-23．

[16]EDMARK C,MCPHAIL M,BELL M,et al.Li Fe:A liver injury score to predict outcome in critically ill patients[J].Intensive Care Med,2016,42(3):361-369．

[17]YAO S,JIANG X,SUN C,et al.External validation and improvement of Li Fe score as a prediction tool in critically ill cirrhosis patients[J].Hepatol Res,2018,48(11):905-913．

[18]GAO F,HUANG XL,CAI MX,et al.Prognostic value of serum lactate kinetics in critically ill patients with cirrhosis and acuteon-chronic liver failure:A multicenter study[J].Aging(Albany NY),2019,11(13):4446-4462．

[19]BERNAL W,DONALDSON N,WYNCOLL D,et al.Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure:A cohort study[J].Lancet,2002,359(9306):558-563．

[20]MACQUILLAN GC,SEYAM MS,NIGHTINGALE P,et al.Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure[J].Liver Transpl,2005,11(9):1073-1079．

[21]CHOLONGITAS E,O’BEIRNE J,BETROSSIAN A,et al.Prognostic impact of lactate in acute liver failure[J].Liver Transpl,2008,14(1):121-122;author reply 123．

[22]BERNAL W.Lactate is important in determining prognosis in acute liver failure[J].J Hepatol,2010,53(1):209-210．

[23]CHEN W,LIN S,CHEN J,et al.Blood lactate level and its prognostic value in HBV-associated subacute-on-chronic liver failure[J].Chin J Viral Dis,2012,2(5):370-373.(in Chinese)陈薇，林苏，陈靖，等．血乳酸对HBV相关慢加亚急性肝衰竭患者预后评估[J]．中国病毒病杂志，2012,2(5):370-373．

[24]XU SL,LUO YM,ZHOU GL.Value of dynamic changes of blood lactate in evaluating short-term prognosis of patients with HBV-related chronic and subacute liver failure[J].Contemp Med,2019,25(27):55-57.(in Chinese)许守连，罗颖敏，周观林．血乳酸值动态变化对HBV相关慢加亚急性肝功能衰竭患者近期预后的评估价值[J]．当代医学，2019,25(27):55-57．

[25]DEVARBHAVI H,CHOUDHURY AK,SHARMA MK,et al.Drug-induced acute-on-chronic liver failure in asian patients[J].Am J Gastroenterol,2019,114(6):929-937．

[26]CHEN J,HU JH,LIU XY,et al.Factors affecting serum lacticemia level in patients with HBV-related acute-on-chronic liver failure[J].Infect Dis Info,2011,24(3):156-158,184.(in Chinese)陈婧，胡瑾华，刘晓燕，等．HBV相关慢加急性肝衰竭患者血乳酸水平影响因素分析[J]．传染病信息，2011,24(3):156-158,184．

[27]TRIANTOS C,KALAFATELI M,AGGELETOPOULOU I,et al.Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis[J].Eur JGastroenterol Hepatol,2017,29(9):998-1003．

[28]DRIEDGER M,GALANAKIS C,DOYLE MA,et al.Direct-acting antiviral hepatitis C virus treatment perturbation of the metabolic milieu[J].Eur J Gastroenterol Hepatol,2019,31(2):260-266．

[29]CHEN W,YOU J,CHEN J,et al.Modified model for endstage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure[J].World JGastroenterol,2017,23(40):7303-7309．

[30]YAO YH,ZHAO WF,GAN JH.Model for end-stage liver disease combined with arterial blood lactate to assess the prognosis of hepatitis B virus-associated acute-on-chronic liver failure:A retrospective analysis of 97 cases[J].Chin J Hepatol,2019,27(4):256-260.(in Chinese)姚运海，赵卫峰，甘建和．终末期肝病模型联合动脉血乳酸对乙型肝炎病毒相关慢加急性肝衰竭预后的评价:97例患者的回顾性分析[J]．中华肝脏病杂志，2019,27(4):256-260．

[31]DROLZ A,HORVATITS T,RUTTER K,et al.Lactate improves prediction of short-term mortality in critically ill patients with cirrhosis:A multinational study[J].Hepatology,2019,69(1):258-269．

[32]CARDOSO FS,ABRALDES JG,SY E,et al.Lactate and number of organ failures predict intensive care unit mortality in patients with acute-on-chronic liver failure[J].Liver Int,2019,39(7):1271-1280．

[33]WANG YG,XIE CY,WANG HB,et al.Correlation between early lactate clearance rate and ALT and AST and its value in evaluating hepatic injury after orthotopic liver transplantation[J].Infect Dis Info,2014,27(2):82-85,92.(in Chinese)王永刚，谢聪颖，王洪波，等．肝移植术后早期乳酸清除率与ALT和AST的相关性及对移植肝损伤的评估研究[J]．传染病信息，2014,27(2):82-85,92．

[34]CONNOLLY C,STATTNER S,NIEDERWIESER T,et al.Systematic review on peri-operative lactate measurements to predict outcomes in patients undergoing liver resection[J].JHepatobiliary Pancreat Sci,2020,27(7):359-370．

[35]GOLSE N,GUGLIELMO N,EL METNI A,et al.Arterial lactate concentration at the end of liver transplantation is an early predictor of primary graft dysfunction[J].Ann Surg,2019,270(1):131-138.

施引文献

期刊类型引用(5)

1.	黄健佳，杨艳，万鑫，周光斌，陈晨，王飞兵，曹华斌. 血浆乳酸动态变化可作为母犬绝育术预后评估的重要参数. 中国兽医杂志. 2024(07): 136-143 . 百度学术
2.	葛孝定，刘斐. 乙型肝炎病毒相关慢加急性肝衰竭的MELD评分变化及意义. 中国现代医生. 2023(13): 15-18 . 百度学术
3.	殷春兰，赵瑞芹，付海燕，白革兰，程丽娟. 血脂及血乳酸在儿童CLD的表达水平及其临床意义. 川北医学院学报. 2023(06): 754-758+763 . 百度学术
4.	谢冰鑫，王娜. 免疫球蛋白联合肝功能指标检测在肝衰竭诊断和预后判断中的价值. 中国医药指南. 2022(10): 107-109 . 百度学术
5.	吴舒沁，吴倩，骆建军，蒋光伟，王黎鹏，邹春喜，杨箬箬，王晓霞，朱新新，孟威. 中心静脉血氧饱和度作为严重创伤低血容量休克患者容量复苏目标的生化指标的研究. 创伤外科杂志. 2021(12): 920-924 . 百度学术